InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Explore the complete record of transactions filed by Farner David, 董事. Officer active across 1 company, notably Evolent Health, Inc.. In total, 2 reports have been recorded. Activity tracked since 10 June 2021. The latest transaction was filed on 9 June 2022 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Farner David
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报2 总计
5,564 股0Class A Common StockSEC:0001628908-22-000075:0
7,785 股0Class A Common StockSEC:0001628908-21-000076:0
2 条申报中的 2 条
About Farner David
David Farner is a Director at Evolent Health, Inc. He contributes to the strategy and governance of the company, bringing his expertise in the healthcare sector. His role on the board is essential in guiding strategic decisions and ensuring regulatory compliance.
